Cristina Emilia Ursu

Dr. Cristina Emilia Ursu

Children Emergency Hospital „Louis Turcanu” Timisoara, European Haemophilia Treatment Centre, Timisoara, 300011, Timis, Romania
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EBEstera Boeriu
Estera Boeriu
SASmaranda Arghirescu
Smaranda Arghirescu
MSMargit Serban
Margit Serban
JPJenel Marian Patrascu
Jenel Marian Patrascu
EBEugen Radu Boia
Eugen Radu Boia
CUCristina Emilia Ursu
Cristina Emilia Ursu
(1) Background: Mild and moderate hemophilia, synonymous with non-severe hemophilia (NSH), are of constant interest for the clinicians. Bleeding occurs usually after trauma, injury, surgery, or inhibitor development, sometimes leading to a shift of the clinical phenotype from mild to severe, even with life-threatening and unexpected outcomes. (2) Methods: We performed a retrospective observational study conducted on 112 persons with congenital coagulopathies, 26 of them with NSH, admitted to our clinic in the period 2000 to 2022. For the diagnosis, we used laboratory studies (complete blood cell count, coagulation assays, biochemistry, thromboelastography, genetic tests) and imaging investigations (X-ray, ultrasound, CT, MRI). We selected four cases confronted with pitfalls of diagnosis and evolution in order to illustrate the sometimes provocative field of NSH. (3) Results: Confronted with challenging cases with under-, missed or delayed diagnosis and severe consequences, we aimed at presenting four such selected cases with mild or moderate hemophilia, real pitfalls in our clinical activity. (4) Conclusions: In the field of NSH, if not timely recognized, tending sometimes to remain ignored by caregivers and patients themselves, we can be confronted with challenging diagnostic situations and life-threatening bleeds.

1 January 2014 in Hamostaseologie
Verified
Journal Article
Closed access
PDF file
MSMargit Serban
Margit Serban
DPD. Poenaru
D. Poenaru
JPJ. Patrascu
J. Patrascu
CUCristina Emilia Ursu
Cristina Emilia Ursu
DSD. Savescu
D. Savescu
DMD. Mihailov
D. Mihailov
Haemophilic arthropathy is a defining feature and a debilitating condition of persons with haemophilia (PwH) in low resource countries. Orthopaedic surgery is unavoidable for patients with high occurrence of joint damage. Aims: We aimed to evaluate the spectrum and outcome of invasive orthopaedic therapies in PwH and von Willebrand diseases (VWD). Patients and methods: Our descriptive observational retrospective study included 131 invasive surgical procedures, performed on 76 consecutive patients, most of them (93.4%) with severe disease, treated in Timisoara’s Haemophilia Center over a period of 12 years; 17.1% had pre-operation anti-FVIII inhibitors. Invasive elective procedures were predominant (90.8%) as compared to emergency measures (9.2%); according to their invasiveness, 20.6% of interventions were major, 44.3% intermediate and 35.1% minor. Results: were good in the majority of cases; significantly reduced joint bleed rate and pain score were the most consistent achievements. The greatest proportion of complications occurred after major (66.7%), compared to moderate (25.6%) and minor (7.7%) interventions. The main threatening complication was the development (3.8%) or increase (4.6%) of inhibitor titer. Local bacterial infections and wound dehiscence complicated the evolution in 4.6% and 0.8 % of cases, respectively; we noticed no blood-borne infections or thrombotic accidents. Low dosage (10.7%) and short duration of substitution (21.4%) led to increased post-surgical bleeding and post-haemorrhagic anaemia. Conclusions: Surgery is a highly demanding intervention in haemophilia, which cannot be ignored in a low resource country. It represents a life or limb-saving and quality of life-improving measure. Hämophylische Arthropatie ist ein definierendes Kennzeichen und ein schwächender Zustand von Personen mit Hämophilie (PmH) in Ländern mit eingeschränkten Ressourcen. Or-thopädische Eingriffe sind unausweichlich für Personen mit einer hohen Wahrscheinlichkeit von Gelenkschäden. Unser Ziel war die Aus-wertung des Spektrums und der Ergebnisse von invasiven orthopädischen Therapien bei PmH und von-Willebrand-Syndrom (VWS). Patienten, Methoden: Unsere deskriptive retrospektive Beobachtung umfasste 131 invasive chirurgische Prozeduren, durchgeführt an 76 aufeinander folgenden Patienten, von denen die meisten (93.4%) schwer erkrankt waren und über 12 Jahre in Timisoara’s Hämophilie-Zentrum behandelt worden waren. 17.1% hatten präoperativ anti-FVIII-Inhibitoren. Elektive invasive Prozeduren waren vorherrschend (90.8%) im Vergleich zu Not-fallmaßnahmen (9.2%). Nach Invasivität wa-ren 20.6% der Eingriffe schwerwiegend, 44.3% mittleren Grades, 35.1% der Eingriffe hatten einen geringen Grad. In den meisten Fällen wurden gute Ergebnisse erzielt; signifikante Verminderung der Rate von Gelenkblutungen und Schmerzen waren die konsistent. Ergebnisse: Der größte Anteil an Komplikationen tauchte nach komplexen Interventionen auf...

30 November 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CBCristina Blag
Cristina Blag
MSMargit Serban
Margit Serban
CUCristina Emilia Ursu
Cristina Emilia Ursu
CPCristina Popa
Cristina Popa
ATAdina Traila
Adina Traila
SASmaranda Arghirescu
Smaranda Arghirescu
A coincidental occurrence of severe haemophilia A and Turner syndrome in a female person is extremely rare (less than 10 cases published). In such challenging cases, a multidisciplinary approach based on medicine of precision with full access to genetic and bio-molecular exploration is indispensable. The article presents an eight-year-old girl, with a family history of haemophilia, without significant disease signs (only post-dental extraction bleeding and a shorter stature). Discordantly, however, the investigations revealed a challenging condition: a genotype of 46,X,i(Xq), with an Isochromosome Xq responsible for the Turner syndrome and simultaneously, for the detrimental transformation, interfering with X chromosome inactivation, of an obligate hemophilia carrier into a severe hemophilia case—two distinct and provocative diseases.

1 April 2017 in Revista Romana de Medicina de Laborator
Verified
Journal Article
Open access
PDF file
MSMargit Serban
Margit Serban
DPDan Poenaru
Dan Poenaru
LCLaura Cernat
Laura Cernat
DSDelia Savescu
Delia Savescu
JPJenel Pătrașcu
Jenel Pătrașcu
SASmaranda Arghirescu
Smaranda Arghirescu
The development of FVIII/FIX inhibitor alloantibodies represents a severe complication requiring specific laboratory evaluation for establishing a life-saving therapy regimen. Our preliminary study aimed at elaborating a laboratory strategy for monitoring the effectiveness of Activated Prothrombin Complex Concentrate (APCC) and recombinant activated factor VII (rFVIIa) in haemophiliacs with inhibitors, by checking the reliability and clinical value of three complementary assays: clotting-time based coagulometry, thrombelastography (TEG) and thrombin generation assay (TGA). The investigations were performed on 7 patients with severe haemophilia A with high titer inhibitors treated for 12 episodes of severe bleedings, 5 of them for surgical interventions. After the administration of bypassing agents (BPAs) the clotting-time based assay brought changes only on prothrombin (p<0.01), potentially signaling a thrombotic risk, without any impact on the global hemostasis. TEG displayed prompt significant improvement only after rFVIIa (90μg/kg). TGA revealed significantly improved values for peak and velocity index, time to peak and start tail after both BPAs. Despite some disparities between biological hemostatic phenotype and clinical response to therapy, we concluded that TEG and TGA are the only current exploratory assays, expressing the quality of haemostatic control, representing a real support for a personalized, adapted therapy in hemophilia with inhibitors.

13 February 2019 in Hamostaseologie
Verified
Journal Article
Closed access
PDF file
MSMargit Serban
Margit Serban
DPDan Vasile Poenaru
Dan Vasile Poenaru
JPJenel Marian Patrascu
Jenel Marian Patrascu
LRLadislau Ritli
Ladislau Ritli
EBEugen Sorin Boia
Eugen Sorin Boia
SASmaranda Arghirescu
Smaranda Arghirescu
Objective In countries with low factor concentrate consumption, disabling joint disease remains the major morbidity in patients with haemophilia. The objective of the present analysis is to express the trend and profile of invasive orthopaedic interventions in our country with low usage of factor replacement, lacking the prophylaxis program until recent years. Patients and Methods This retrospective descriptive study was conducted in our university centre in Timisoara with long-lasting experience in haemophilia care, which succeeded in developing an exceptionally valuable genuine comprehensive inter-institutional cooperation. This study refers to 115 invasive interventions performed on 97 patients: 83 with haemophilia A, 10 with haemophilia B and 4 with von Willebrand disease in the period of 2001 to 2017; 17 of them had inhibitors, 5 developing inhibitors after the intervention. Results and Discussion The cohort of patients consisted mostly of young adults, aged between 7 and 49 years. The vast majority of them, 91.3% of the patients, had the burden of severe chronic arthropathy. This was the reason for 95 interventions, with programmed solution. In 20 cases the cause of invasive interventions was emergency. Knee and hip replacement represented 28% of the major interventions. The complications we encountered were excessive bleeding (12.2%), infection (13%) and inhibitor development (4.3%). Conclusion Surgery is a demanding intervention in patients with haemophilia, which unfortunately cannot be ignored in our country. Hopefully, the improved availability and accessibility to replacement therapy will eliminate the necessity of these interventions, optimizing the outcomes for the next generations.

1 November 2011
Verified
Journal Article
Closed access
MSMargit Serban
Margit Serban
DMD. Mihailov
D. Mihailov
LPL. Pop
L. Pop
HIH. Ionita
H. Ionita
CUCristina Emilia Ursu
Cristina Emilia Ursu
WSW. Schramm
W. Schramm